This document is a forensic extraction of an iMessage log from February 2017 between 'jee' (associated with the email jeeitunes@gmail.com) and a redacted sender who identifies herself as 'Melanie'. The exchange includes links to articles about economic 'cost disease' and AI in medicine (IBM Watson), followed by Melanie providing a new mobile phone number (206-382-7848). The document originates from the House Oversight Committee records.
This document is an email from Sultan Bin Sulayem to Jeffrey Epstein dated July 24, 2015. Sulayem forwards a Forbes article regarding the FDA approval of a new cholesterol-lowering drug called Praluent (by Regeneron Pharmaceuticals) and asks Epstein if he has heard of it. The document bears a House Oversight Bates stamp.
This document is an email from Jeffrey Epstein to Sultan Bin Sulayem on July 24, 2015, discussing a new, expensive cholesterol-lowering drug called Praluent. Epstein's email is a reply to an inquiry from Sulayem, who had forwarded a Forbes article announcing the FDA's approval of the drug, which is administered as a shot.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity